The mice model market is projected to reach USD 2.7 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 13.9% during the forecast period. The key factors driving the growth of the mice model market are its various advantages in the drug discovery s…
Global Peptide Microarray Market Size study & Forecast, by Type( Instrument, Reagents and Services) by Application ( Disease Diagnostics, Protein Functional Analysis, Antibody Characterization and Drug Discovery), by End User( Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Diagnostic Centres and Others) and Regional Analysis, 2022-2029
Clinical Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service, Proteomics Service), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others), By company and By Region
Europe Humanized Mice Model Market By Type (Genetic Humanized Mice Model v/s Cell-Based Humanized Mice Model), By Application (Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Others), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations), By Country, Competition, Forecast & Opportunities, 2028
Personalized Medicine Market By Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics), By Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, Others), By End User (Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Global Research Antibodies and Reagents Market by Product (Reagent, Antibodies), by Form (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Mice, Rabbit, Other Sources), by Technologies (Western Blotting, Flow Cytometry, Enzyme-linked, Immunosorbent Assay, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Other Technologies), by Application (Proteomics, Drug Development, Genomics), by End User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), by Region (North America, Latin America, Europe, Asia- Pacific, Middle East, and Africa) - 2023 to 2033
Custom Antibody Market by Service (Development, Purification, Labelling), Type (Monoclonal, Recombinant), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology), End User (Biopharma, CROs) - Global Forecast to 2028
Biomarkers Market by Product & Service (Consumable, Service, Software), Type (Safety, Efficacy, Validation), Disease (Cancer, Infectious, Neurological), Application (Diagnostics, Drug Discovery, Personalized Medicine), Region - Global Forecast to 2028